RARE

ULTRAGENYX PHARMACEUTICAL INC

Healthcare | Mid Cap

-$1.59

EPS Forecast

$142.9

Revenue Forecast

Announcing earnings for the quarter ending 2025-03-31 soon

Market expectations

EPS Expectation:

-$1.59

Revenue Expectation:

$142.9

EPS Surprise Expectation:

-$0.009

Revenue Surprise Expectation:

$0

Post-release price volatility - High

Post-release Overnight Move:

±9.0%

Post-release 1-week Move:

Expected price impact

If company results match EPS & revs consensus exactly:

If company results match Proximilar expectations exactly:

Earnings volatility

EPS standard deviation:

Revenue standard deviation:

As % of share price:

As % of market cap: